Save with Curelo
Switch to an alternative more affordable treatment option (e.g. Wegovy), where clinically appropriate
Continue with your current treatment (e.g. Mounjaro) under clinical guidance
Our clinical team supports safe transitions between treatments
If a treatment isn't suitable, we'll help you adjust your plan
(£xx.xx per dose)
Discreet next day delivery
100% UK-based pharmacy
Free advice and support
Rated 4.8 out of 5
Yes, switching medications is common practice by medical professionals. Our goal is to find the safest, most effective option for your needs.
Clinical trials have demonstrated mean weight loss of around 15–17% at 68–72 weeks in patients receiving semaglutide 2.4mg alongside lifestyle changes.
When switching, treatment is typically restarted at a lower dose to reduce side effects and allow safe titration.
Semaglutide has demonstrated cardiovascular risk reduction in clinical trials in certain patient populations. Additional contraceptive precautions may be required if significant gastrointestinal side effects occur.
Place your Wegovy order using our switching guidelines and selecting the most suitable starting dose.
We will review your order and work with you to adjust the dose if needed to ensure a safe switch.
You will receive your order but will need to wait seven days after your last Mounjaro injection before starting Wegovy.
* Effectiveness: In studies, the highest dose of Mounjaro led to an average weight loss of up to 22.5%. Wegovy users lost around 17% of their weight in 72 weeks with diet and exercise changes.
† Long-term studies found injection site reactions in 0.3% of Wegovy users and 8.6% of Mounjaro users.
‡ Wegovy is currently the only GLP-1 licensed for cardiovascular risk reduction.
Continuing with your current treatment is a safe and supported choice. Our clinical team will ensure Mounjaro remains an effective option for your needs.
Clinical trials show an average 20% body weight loss over 72 weeks with Mounjaro.
Continue re-ordering as normal, you may decide to increase or maintain your current dose.
Stepping down to a lower Mounjaro dose can still give meaningful benefits at a lower cost.
Eli Lilly, the manufacturer of Mounjaro, has increased the price of all dose strengths in the UK to align with prices across mainland Europe. This change means that in the UK, Wegovy is now a more cost-effective GLP-1 treatment option for weight management.
The easiest way to switch is through our dedicated switching service. Simply complete our consultation form and our clinical team will guide you through a safe transition. When switching, treatment is typically restarted at a lower dose to reduce side effects and allow safe titration. You will need to wait seven days after your last Mounjaro injection before starting Wegovy.
If you’re doing well on Mounjaro, most experts recommend staying on it. If cost is a concern, switching to Wegovy may be considered. Whatever you decide, our team is here to support and guide you.
When switching, treatment is typically restarted at a lower dose of Wegovy and titrated up under clinical supervision. Your prescriber will recommend the most appropriate starting dose for you, and your titration may be slightly quicker than someone starting Wegovy for the first time.
Yes. Wegovy is gradually increased to a maintenance dose of 2.4mg once weekly, which is the licensed long-term dose in the UK. Treatment can continue for as long as it remains clinically beneficial, with regular reviews from our prescribing team.
Complete our online questionnaire so our medical team can check your
eligibility for Wegovy.
